Genomic Revolution Multi-Sector ETF Blog | Talkmarkets | Page 2
No data available
No data available

People who follow this stock (14)

Latest Posts

About This Stock More About This Stock
Longevity Stocks
Article By: Fred Fuld
Monday, December 14, 2020 4:13 AM EST
There are several companies working on helping you achieve a greater longevity, which are involved in targeting human aging and degenerative diseases. Here are several that are close to longevity pure plays.
In this article: ACET, LNGR, ARKG, UBX, CWBR, AGE, LCTX Also: MSFT, PYPL
ETFs In Focus On Bayer's Bet On Gene Therapy
Article By: Sweta Killa
Thursday, October 29, 2020 11:58 PM EST
Merger and acquisition activities have heated up in recent months and the niche spaces are in the limelight. After the telemedicine industry, gene therapy stocks jumped on the bandwagon.
In this article: GNOM, PBE, ARKG, IDNA
4 Sector ETFs That Have Doubled This Year
Article By: Sweta Killa
Friday, October 23, 2020 5:20 PM EST
While there have been winners in many corners of the space, we highlight four sector ETFs that have doubled so far this year:
In this article: XVZ, TAN, ARKW, ARKG
FV Why You Should Invest In Genomics ETFs
Video By: Neena Mishra
Thursday, October 15, 2020 1:09 PM EST
Biotech ETFs have done quite well this year as many pharma and biotech companies are working on coronavirus vaccines, therapeutics, and testing.
In this video: GNOM, ARKG, IDNA Also: REGN, GILD, NVTA, CRSP
Top-Performing Biotechnology ETFs Amid Coronavirus Outbreak
Article By: Zacks Investment Research
Tuesday, July 14, 2020 2:00 AM EST
The coronavirus outbreak seems to get severe in the United States as more than 3.3 million cases have been recorded with a death toll of at least 135,205.
In this article: BIB, XBI, ARKG, IDNA

Latest Tweets for $ARKG

No tweets yet!